Hydronephrosis Treatment Market, Global Outlook and Forecast 2022-2028

April 2022 | 65 pages | ID: H86725438F0DEN
Market Monitor Global

Abstracts

Hydronephrosis is a condition characterized by a swollen kidney as a result of abnormal drainage of urine from the kidney to the bladder. It is a secondary disease that results from primary disease that may affect the kidney.

This report contains market size and forecasts of Hydronephrosis Treatment in Global, including the following market information:

Global Hydronephrosis Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Hydronephrosis Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Surgical Treatment Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Hydronephrosis Treatment include NephroGenex, PHRAXIS, Allergan, Amgen, Anthem Group, Sanofi and Novartis, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Hydronephrosis Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Hydronephrosis Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Hydronephrosis Treatment Market Segment Percentages, by Type, 2021 (%)

• Surgical Treatment
• Drug Treatment

Global Hydronephrosis Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Hydronephrosis Treatment Market Segment Percentages, by Application, 2021 (%)

• Hospital
• Clinic
• Ambulatory Surgery Centre

Global Hydronephrosis Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Hydronephrosis Treatment Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Hydronephrosis Treatment revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Hydronephrosis Treatment revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• NephroGenex
• PHRAXIS
• Allergan
• Amgen
• Anthem Group
• Sanofi
• Novartis

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Hydronephrosis Treatment Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Hydronephrosis Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL HYDRONEPHROSIS TREATMENT OVERALL MARKET SIZE

2.1 Global Hydronephrosis Treatment Market Size: 2021 VS 2028
2.2 Global Hydronephrosis Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Hydronephrosis Treatment Players in Global Market
3.2 Top Global Hydronephrosis Treatment Companies Ranked by Revenue
3.3 Global Hydronephrosis Treatment Revenue by Companies
3.4 Top 3 and Top 5 Hydronephrosis Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies Hydronephrosis Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Hydronephrosis Treatment Players in Global Market
  3.6.1 List of Global Tier 1 Hydronephrosis Treatment Companies
  3.6.2 List of Global Tier 2 and Tier 3 Hydronephrosis Treatment Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Hydronephrosis Treatment Market Size Markets, 2021 & 2028
  4.1.2 Surgical Treatment
  4.1.3 Drug Treatment
4.2 By Type - Global Hydronephrosis Treatment Revenue & Forecasts
  4.2.1 By Type - Global Hydronephrosis Treatment Revenue, 2017-2022
  4.2.2 By Type - Global Hydronephrosis Treatment Revenue, 2023-2028
  4.2.3 By Type - Global Hydronephrosis Treatment Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Hydronephrosis Treatment Market Size, 2021 & 2028
  5.1.2 Hospital
  5.1.3 Clinic
  5.1.4 Ambulatory Surgery Centre
5.2 By Application - Global Hydronephrosis Treatment Revenue & Forecasts
  5.2.1 By Application - Global Hydronephrosis Treatment Revenue, 2017-2022
  5.2.2 By Application - Global Hydronephrosis Treatment Revenue, 2023-2028
  5.2.3 By Application - Global Hydronephrosis Treatment Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Hydronephrosis Treatment Market Size, 2021 & 2028
6.2 By Region - Global Hydronephrosis Treatment Revenue & Forecasts
  6.2.1 By Region - Global Hydronephrosis Treatment Revenue, 2017-2022
  6.2.2 By Region - Global Hydronephrosis Treatment Revenue, 2023-2028
  6.2.3 By Region - Global Hydronephrosis Treatment Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Hydronephrosis Treatment Revenue, 2017-2028
  6.3.2 US Hydronephrosis Treatment Market Size, 2017-2028
  6.3.3 Canada Hydronephrosis Treatment Market Size, 2017-2028
  6.3.4 Mexico Hydronephrosis Treatment Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Hydronephrosis Treatment Revenue, 2017-2028
  6.4.2 Germany Hydronephrosis Treatment Market Size, 2017-2028
  6.4.3 France Hydronephrosis Treatment Market Size, 2017-2028
  6.4.4 U.K. Hydronephrosis Treatment Market Size, 2017-2028
  6.4.5 Italy Hydronephrosis Treatment Market Size, 2017-2028
  6.4.6 Russia Hydronephrosis Treatment Market Size, 2017-2028
  6.4.7 Nordic Countries Hydronephrosis Treatment Market Size, 2017-2028
  6.4.8 Benelux Hydronephrosis Treatment Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Hydronephrosis Treatment Revenue, 2017-2028
  6.5.2 China Hydronephrosis Treatment Market Size, 2017-2028
  6.5.3 Japan Hydronephrosis Treatment Market Size, 2017-2028
  6.5.4 South Korea Hydronephrosis Treatment Market Size, 2017-2028
  6.5.5 Southeast Asia Hydronephrosis Treatment Market Size, 2017-2028
  6.5.6 India Hydronephrosis Treatment Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Hydronephrosis Treatment Revenue, 2017-2028
  6.6.2 Brazil Hydronephrosis Treatment Market Size, 2017-2028
  6.6.3 Argentina Hydronephrosis Treatment Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Hydronephrosis Treatment Revenue, 2017-2028
  6.7.2 Turkey Hydronephrosis Treatment Market Size, 2017-2028
  6.7.3 Israel Hydronephrosis Treatment Market Size, 2017-2028
  6.7.4 Saudi Arabia Hydronephrosis Treatment Market Size, 2017-2028
  6.7.5 UAE Hydronephrosis Treatment Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 NephroGenex
  7.1.1 NephroGenex Corporate Summary
  7.1.2 NephroGenex Business Overview
  7.1.3 NephroGenex Hydronephrosis Treatment Major Product Offerings
  7.1.4 NephroGenex Hydronephrosis Treatment Revenue in Global Market (2017-2022)
  7.1.5 NephroGenex Key News
7.2 PHRAXIS
  7.2.1 PHRAXIS Corporate Summary
  7.2.2 PHRAXIS Business Overview
  7.2.3 PHRAXIS Hydronephrosis Treatment Major Product Offerings
  7.2.4 PHRAXIS Hydronephrosis Treatment Revenue in Global Market (2017-2022)
  7.2.5 PHRAXIS Key News
7.3 Allergan
  7.3.1 Allergan Corporate Summary
  7.3.2 Allergan Business Overview
  7.3.3 Allergan Hydronephrosis Treatment Major Product Offerings
  7.3.4 Allergan Hydronephrosis Treatment Revenue in Global Market (2017-2022)
  7.3.5 Allergan Key News
7.4 Amgen
  7.4.1 Amgen Corporate Summary
  7.4.2 Amgen Business Overview
  7.4.3 Amgen Hydronephrosis Treatment Major Product Offerings
  7.4.4 Amgen Hydronephrosis Treatment Revenue in Global Market (2017-2022)
  7.4.5 Amgen Key News
7.5 Anthem Group
  7.5.1 Anthem Group Corporate Summary
  7.5.2 Anthem Group Business Overview
  7.5.3 Anthem Group Hydronephrosis Treatment Major Product Offerings
  7.5.4 Anthem Group Hydronephrosis Treatment Revenue in Global Market (2017-2022)
  7.5.5 Anthem Group Key News
7.6 Sanofi
  7.6.1 Sanofi Corporate Summary
  7.6.2 Sanofi Business Overview
  7.6.3 Sanofi Hydronephrosis Treatment Major Product Offerings
  7.6.4 Sanofi Hydronephrosis Treatment Revenue in Global Market (2017-2022)
  7.6.5 Sanofi Key News
7.7 Novartis
  7.7.1 Novartis Corporate Summary
  7.7.2 Novartis Business Overview
  7.7.3 Novartis Hydronephrosis Treatment Major Product Offerings
  7.7.4 Novartis Hydronephrosis Treatment Revenue in Global Market (2017-2022)
  7.7.5 Novartis Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Hydronephrosis Treatment Market Opportunities & Trends in Global Market
Table 2. Hydronephrosis Treatment Market Drivers in Global Market
Table 3. Hydronephrosis Treatment Market Restraints in Global Market
Table 4. Key Players of Hydronephrosis Treatment in Global Market
Table 5. Top Hydronephrosis Treatment Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Hydronephrosis Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Hydronephrosis Treatment Revenue Share by Companies, 2017-2022
Table 8. Global Companies Hydronephrosis Treatment Product Type
Table 9. List of Global Tier 1 Hydronephrosis Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Hydronephrosis Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Hydronephrosis Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Hydronephrosis Treatment Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Hydronephrosis Treatment Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Hydronephrosis Treatment Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Hydronephrosis Treatment Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Hydronephrosis Treatment Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Hydronephrosis Treatment Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Hydronephrosis Treatment Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Hydronephrosis Treatment Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Hydronephrosis Treatment Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Hydronephrosis Treatment Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Hydronephrosis Treatment Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Hydronephrosis Treatment Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Hydronephrosis Treatment Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Hydronephrosis Treatment Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Hydronephrosis Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Hydronephrosis Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Hydronephrosis Treatment Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Hydronephrosis Treatment Revenue, (US$, Mn), 2023-2028
Table 30. NephroGenex Corporate Summary
Table 31. NephroGenex Hydronephrosis Treatment Product Offerings
Table 32. NephroGenex Hydronephrosis Treatment Revenue (US$, Mn), (2017-2022)
Table 33. PHRAXIS Corporate Summary
Table 34. PHRAXIS Hydronephrosis Treatment Product Offerings
Table 35. PHRAXIS Hydronephrosis Treatment Revenue (US$, Mn), (2017-2022)
Table 36. Allergan Corporate Summary
Table 37. Allergan Hydronephrosis Treatment Product Offerings
Table 38. Allergan Hydronephrosis Treatment Revenue (US$, Mn), (2017-2022)
Table 39. Amgen Corporate Summary
Table 40. Amgen Hydronephrosis Treatment Product Offerings
Table 41. Amgen Hydronephrosis Treatment Revenue (US$, Mn), (2017-2022)
Table 42. Anthem Group Corporate Summary
Table 43. Anthem Group Hydronephrosis Treatment Product Offerings
Table 44. Anthem Group Hydronephrosis Treatment Revenue (US$, Mn), (2017-2022)
Table 45. Sanofi Corporate Summary
Table 46. Sanofi Hydronephrosis Treatment Product Offerings
Table 47. Sanofi Hydronephrosis Treatment Revenue (US$, Mn), (2017-2022)
Table 48. Novartis Corporate Summary
Table 49. Novartis Hydronephrosis Treatment Product Offerings
Table 50. Novartis Hydronephrosis Treatment Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Hydronephrosis Treatment Segment by Type in 2021
Figure 2. Hydronephrosis Treatment Segment by Application in 2021
Figure 3. Global Hydronephrosis Treatment Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Hydronephrosis Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Hydronephrosis Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Hydronephrosis Treatment Revenue in 2021
Figure 8. By Type - Global Hydronephrosis Treatment Revenue Market Share, 2017-2028
Figure 9. By Application - Global Hydronephrosis Treatment Revenue Market Share, 2017-2028
Figure 10. By Region - Global Hydronephrosis Treatment Revenue Market Share, 2017-2028
Figure 11. By Country - North America Hydronephrosis Treatment Revenue Market Share, 2017-2028
Figure 12. US Hydronephrosis Treatment Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Hydronephrosis Treatment Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Hydronephrosis Treatment Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Hydronephrosis Treatment Revenue Market Share, 2017-2028
Figure 16. Germany Hydronephrosis Treatment Revenue, (US$, Mn), 2017-2028
Figure 17. France Hydronephrosis Treatment Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Hydronephrosis Treatment Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Hydronephrosis Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Hydronephrosis Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Hydronephrosis Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Hydronephrosis Treatment Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Hydronephrosis Treatment Revenue Market Share, 2017-2028
Figure 24. China Hydronephrosis Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Hydronephrosis Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Hydronephrosis Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Hydronephrosis Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. India Hydronephrosis Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Hydronephrosis Treatment Revenue Market Share, 2017-2028
Figure 30. Brazil Hydronephrosis Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Hydronephrosis Treatment Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Hydronephrosis Treatment Revenue Market Share, 2017-2028
Figure 33. Turkey Hydronephrosis Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Hydronephrosis Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Hydronephrosis Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Hydronephrosis Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. NephroGenex Hydronephrosis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. PHRAXIS Hydronephrosis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Allergan Hydronephrosis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Amgen Hydronephrosis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Anthem Group Hydronephrosis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Sanofi Hydronephrosis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Novartis Hydronephrosis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)